XTL Biopharmaceuticals Lt... (XTLB)

AI Score

Unlock

1.14

-0.02 (-1.72%)

At close: Apr 17, 2025, 2:23 PM

XTL Biopharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	1.4M	2.09M	2.97M	3.63M	4.46M	3.25M	3.29M	2.02M
Short-Term Investments	605K	1.63M	3.16M	2.41M	2.27M	4.87M	2.81M	414K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	85K	130K
Other Current Assets	11K	14K	16K	13K	20K	n/a	n/a	191K
Total Current Assets	2.05M	3.81M	6.24M	6.12M	6.83M	8.2M	6.21M	2.75M
Property-Plant & Equipment	n/a	n/a	1K	2K	2K	n/a	n/a	10K
Goodwill & Intangibles	380K	380K	380K	380K	380K	380K	380K	253K
Total Long-Term Assets	380K	380K	381K	382K	382K	380K	380K	263K
Total Assets	2.43M	4.19M	6.62M	6.5M	7.21M	8.57M	6.59M	3.02M
Account Payables	1K	2K	2K	2K	1K	253K	4K	17K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	206K	187K	231K	254K	232K	253K	300K	330K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	1.05M	2.64M	n/a	n/a	2.67M	n/a
Total Long-Term Liabilities	n/a	n/a	1.05M	2.64M	n/a	n/a	2.67M	n/a
Total Liabilities	206K	187K	1.28M	254K	232K	253K	2.97M	330K
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	14.12M	14.12M	14.12M	13.18M	13.18M	13.18M	13.18M	6.62M
Retained Earnings	-158.25M	-156.47M	-155.13M	-154.66M	-153.93M	-152.59M	-155.65M	-154.9M
Comprehensive Income	20K	20K	20K	20K	20K	20K	67K	183K
Shareholders Equity	2.22M	4M	5.33M	6.25M	6.98M	8.32M	3.62M	2.69M
Total Investments	605K	1.63M	3.16M	2.41M	2.27M	4.87M	2.81M	414K